CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma

CXC ligand 17 (CXCL17) is a novel CXC chemokine whose clinical significance remains largely unknown. In the present study, we characterized the prognostic value of CXCL17 in patients with hepatocellular carcinoma (HCC) and evaluated the association of CXCL17 with immune infiltration. We examined CXC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Yan, Jing, Xu, Jing, Liu, Chao-Qun, Zhen, Zuo-Jun, Chen, Huan-Wei, Ji, Yong, Wu, Zhi-Peng, Hu, Jian-Yuan, Zheng, Limin, Lau, Wan Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193880/
https://www.ncbi.nlm.nih.gov/pubmed/25303284
http://dx.doi.org/10.1371/journal.pone.0110064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193880/
https://www.ncbi.nlm.nih.gov/pubmed/25303284
http://dx.doi.org/10.1371/journal.pone.0110064

Ejemplares similares